AbelZeta Pharma

Enabling Immunity

Through innovative and proprietary T-cell-based therapeutics.

Enabling Immunity

Through innovative and proprietary T-cell-based therapeutics.

AbelZeta is a cell therapy leader focused on discovering, developing and manufacturing therapeutics to address unmet medical needs in oncology and inflammatory and immunological diseases.

Hematologic Malignancies

Inflammatory & Immunological

Solid Tumors

Our PlatformS

AUTOLOGOUS CAR-T and IN-VIVO CAR-T

Chimeric Antigen Receptor (CAR)-T Cell

EMPOWERING YOUR IMMUNE SYSTEM

A Personalized Fight Against Cancer and Inflammatory & Immunological Diseases

Scroll to Top